| (USD) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -3.90M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, MNPR returned +236.0% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +65.0% |
| 1 year | +236.0% |
| 5 years | +316.7% |
| All-time high | $108.35 (Jul 2026) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in MNPR would be worth today ›No. Monopar Therapeutics Inc. has not paid a dividend in the past 12 months.
Monopar Therapeutics Inc. stock trades on NASDAQ under the ticker symbol MNPR.
Monopar Therapeutics Inc. is part of the Healthcare sector.
Monopar Therapeutics Inc. has a market cap of 723.04M USD, based on the latest quote.
Monopar Therapeutics Inc. is expected to report earnings around Nov 12, 2026. That date is an estimate and has not been confirmed by the company.
